Akbarzadeh M,Eftekhari MH,Dabbaghmanesh MH,Hasanzadeh J,Bakhshayeshkaram M .2013 .Serum Il-18 and hs-CRP correlate with insulin resistance without effect of calcitriol treatment on type 2 diabetes. Iran J. Immunol., 10(3) : 167-176.
Al-Rashed F,Ahmad Z,Iskandar MA,Tuomilehto J,AlMulla F and Ahmad R J .2019 .TNF-alpha induces A pro-inflammatory phenotypic shift in monocytes through Acsl1: Relevance to metabolic inflammation. Cell. Physiol. Biochem., 52 : 397-407.
Anari R,Amani R,Latifi SM,Veissi M,Shahbazian H M .2017 .Association of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects. Diabetes Metab Syndr:, 11(1) : 37-41.
Andrews Guzman M and Arredondo Olguin M .2014 .Association between ferritin, high sensitivity Creactive protein (hs-CRP) and relative abundance of hepcidin mrna with the risk of type 2 diabetes in obese subjects. Nutr, 30(3) : 577-584.
Anjana M,Sandeep S,Deepa R,Vimaleswaran KS,Farooq S,Mohan V .2004 .Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians. Diabetes Care, 27(12) : 2948-2953.
Basit A,Askari S,Zafar J,Riaz M,Fawwad A,Members N A .2016 .NDSP 06: Prevalence and risk factors for obesity in urban and rural areas of Pakistan: A study from Second National Diabetes Survey of Pakistan (NDSP. Res. Clin. Pract, 15(1) : 19-25.
Catalina MOS,Redondo PC,Granados MP,Cantonero C,Sanchez-Collado J,Albarran L,Lopez JJ .2019 .New insights into adipokines as potential biomarkers for type-2 diabetes mellitus. Curr. Med, 26(22) : 4119-4144.
Chan M .2017 .Obesity and diabetes: The slow-motion disaster. Milbank Q, 95(1) : 11.
Cheng L,Zhuang H,Yang S,Jiang H,Wang S,Zhang J .2018 .Exposing the causal effect of c-reactive protein on the risk of type 2 diabetes mellitus: A mendelian randomization study. Frontiers in Genetics, 9(1) : 657.
De Maranon AM,Iannantuoni F,Abad-Jimenez Z,Canet F,Díaz-Pozo P,Lopez-Domenech S,Roldan-Torres I,Morillas C,Rocha M,Víctor VM .2020 .Association between proinflammatory markers, leukocyte-endothelium interactions, and carotid intima-media thickness in type 2 diabetes: Role of glycemic control. Clin. Med, 9(8) : 2522.
Demyanets S,Kaun C,Kaider A,Speidl W,Prager M,Oravec S,Hohensinner P,Wojta J,Rega-Kaun G .2020 .The pro-inflammatory marker soluble suppression of tumorigenicity-2 (St2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery. Cardiovasc Diabetol, 19(1) : 26.
Elimam H,Abdulla AM,Taha IM .2019 .Inflammatory markers and control of type 2 diabetes mellitus. Diabetes Metab, 13(1) : 800-804.
Esser N,Legrand-Poels S,Piette J,Scheen AJ,Paquot N AJ .2014 .Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Prac, 105(2) : 141-150.
Fadaei R,Bagheri N,Heidarian E,Nouri A,Hesari Z,Moradi N,Ahmadi A,Ahmadi R .2020 .Serum levels of Il-32 in patients with type 2 diabetes mellitus and its relationship with tnf-alpha and I1-6. , 125(1) : 154832.
Fossati P and Prencipe L .1982 .Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem, 28(10) : 2077-2080.
Gastaldelli A .2008 .Abdominal fat: Does it predict the development of type 2 diabetes. , : .
Hedlund P .1961 .Clinical and experimental studies on creactive protein (acute phase protein). Acta Medica Scandinavica. Supplementum, 361 : 1-71.
Kishimoto T,Akira S,Taga T .1992 .Interleukin-6 and its receptor: A paradigm for cytokines. Science, 258(5082) : 593-597.
Lainampetch J,Panprathip P,Phosat C,Chumpathat N,Prangthip P,Soonthornworasiri N,Puduang S,Wechjakwen N,Kwanbunjan K .2019 .Association of tumor necrosis factor alpha, interleukin 6, and c-reactive protein with the risk of developing type 2 diabetes: A retrospective cohort study of rural thais. J. Diabetes Res., 9051929 : .
Lee C,Adler A,Sandhu M,Sharp S,Forouhi N,Erqou S,Luben R,Bingham S,Khaw K,Wareham N K .2009 .Association of c-reactive protein with type 2 diabetes: Prospective analysis and meta-analysis. Diabetologia, 52(3) : 1040-1047.
Levy JC,Matthews DR,Hermans MP .1998 .Correct homeostasis model assessment (Homa) evaluation uses the computer program. Diabetes Care, 21(12) : 2191-2192.
Marques-Vidal P,Bastardot F,Von Kanel R,Paccaud F,Preisig M,Waeber G,Vollenweider P .2013 .Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (colaus study). Clin Endocrinol (Oxf), 78(2) : 232-241.
Milas O,Gadalean F,Vlad A,Dumitrascu V,Velciov S,Gluhovschi C,Bob F,Popescu R,Ursoniu S,Jianu DC,Matusz P,Pusztai AM,Secara A,Simulescu A,Stefan M,Patruica M,Petrica F,Vlad D,Petrica L D .2020 .Pro-Inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients. J. Diabetes Complications, 34(2) : 107479.
Mtintsilana A,Micklesfield LK,Chorell E,Olsson T,Shivappa N,Hebert JR,Kengne AP,Goedecke JH .2019 .Adiposity mediates the association between the dietary inflammatory index and markers of type 2 diabetes risk in middle-aged black south african women. Nutrients, 11(6) : 1246.
Nadeem A,Naveed AK,Hussain MM,Raza SI .2013 .Correlation of inflammatory markers with type 2 diabetes mellitus in Pakistani patients. J. Postgrad. Med, 27 : .
Organization WH .2003 .. The World Health Report 2003: Shaping The Future, World Health Organization., : .
Phosat C,Panprathip P,Chumpathat N,Prangthip P,Chantratita N,Soonthornworasiri N,Puduang S,Kwanbunjan K S .2017 .Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural thais: A cross-sectional study. Bmc Endocr Disord, 17(1) : 44.
Pickup JC .2004 .Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 27(3) : 813-823.
Pickup JC .2006 .Inflammatory markers and type 2 diabetes. Diabetes Technol The., 8, (1) : 1-6.
Shiwaku K,Anuurad E,Enkhmaa B,Nogi A,Kitajima K,Yamasaki M,Yoneyama T,Oyunsuren T,Yamane Y .2005 .predictive values of anthropometric measurements for multiple metabolic disorders in asian populations. Diabetes Res. Clin. Pract, 69(1) : 52-62.
Simental-Mendia LE,Lazalde B,Zambrano-Galvan G,Simental-Saucedo L,Rabago-Sanchez E,RodriguezMoran M,Guerrero-Romero F .2012 .Relation between c-reactive protein and impaired fasting glucose in obese subjects. Inflammation, 35 : 1742-6.
Singh R,Shaw J,Zimmet P .2004 .Epidemiology of childhood type 2 diabetes in the developing world. Pediatric Diabetes, 5(3) : 154-168.
Songa RM,Siddhartha K,Sudhakar K K .2013 .Lipidprofile in type2 diabetes mellitus with obesity. Bopams, 1(2) : 132-137.
Tangvarasittichai S,Pongthaisong S,Tangvarasittichai O .2016 .Tumor necrosis factor-alpha, interleukin-6, c-reactive protein levels and insulin resistance associated with type 2 diabetes in abdominal obesity women. Indian J. Clin Biochem., 31(1) : 68-74.
Trinder P .1969 .Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann.Clin. Bioch, 6(1) : 24-27.
Valtierra-Alvarado MA,Castaneda Delgado JE,RamirezTalavera SI,Lugo-Villarino G,Duenas-Arteaga F,Lugo-Sanchez A,Adame-Villalpando MS,RivasSantiago B,Enciso-Moreno J,Serrano CJ .2020 .Type 2 diabetes mellitus metabolic control correlates with the phenotype of human monocytes and monocyte-derived macrophages. J. Diabetes Complications, 34(11) : 107708.